Karpov, D.S.; Sosnovtseva, A.O.; Pylina, S.V.; Bastrich, A.N.; Petrova, D.A.; Kovalev, M.A.; Shuvalova, A.I.; Eremkina, A.K.; Mokrysheva, N.G.
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”. Int. J. Mol. Sci. 2023, 24, 17320.
https://doi.org/10.3390/ijms242417320
AMA Style
Karpov DS, Sosnovtseva AO, Pylina SV, Bastrich AN, Petrova DA, Kovalev MA, Shuvalova AI, Eremkina AK, Mokrysheva NG.
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”. International Journal of Molecular Sciences. 2023; 24(24):17320.
https://doi.org/10.3390/ijms242417320
Chicago/Turabian Style
Karpov, Dmitry S., Anastasiia O. Sosnovtseva, Svetlana V. Pylina, Asya N. Bastrich, Darya A. Petrova, Maxim A. Kovalev, Anastasija I. Shuvalova, Anna K. Eremkina, and Natalia G. Mokrysheva.
2023. "Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”" International Journal of Molecular Sciences 24, no. 24: 17320.
https://doi.org/10.3390/ijms242417320
APA Style
Karpov, D. S., Sosnovtseva, A. O., Pylina, S. V., Bastrich, A. N., Petrova, D. A., Kovalev, M. A., Shuvalova, A. I., Eremkina, A. K., & Mokrysheva, N. G.
(2023). Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”. International Journal of Molecular Sciences, 24(24), 17320.
https://doi.org/10.3390/ijms242417320
